The clinical trials below are available in the specialty you selected. Choose a different specialty.
Development of Prognostic Platelet RNA Biomarkers to Tailor Antiplatelet Therapy
Healthy volunteers and people with Type 2 Diabetes are needed to participate in an aspirin research study at the Duke Clinical Research Unit. The study will evaluate the effect of aspirin and ticagrelor (an antiplatelet agent similar to aspirin) on the genomic profiles of whole blood and platelets.
Study participation will involve 5 or 6 visits to the DCRU over the course of approximately 5 months. The aspirin & ticagrelor therapy for participants will last 16 weeks. Financial compensation is provided for participation. (REF# 00048621)
SAPPHIRE World Wide Registry
Duke Cardiac Catheterization Lab is seeking research subjects with carotid stenosis to participate in a carotid stent high-risk registry. (REF# 2225)
Researchers are seeking healthy volunteers for participation in a study aimed at reducing the risk of heart disease and type 2 diabetes in at-risk individuals. (REF# 16540)
A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)
The purpose of this clinical trial is to evaluate the carotid stent vs. surgery trial by studying individuals with carotid stenosis. (REF# 10162)
Renal Denervation in Patients with Uncontrolled Hypertension -- SYMPLICITY HTN-3
Patients with uncontrolled hypertension are needed for a research study. (REF# 33607)
We are recruiting subjects for a clinical trial of exercise and stress management called ENHANCED. (REF# 15896)
This study seeks adults with mitral regurgitation (MR) who are seeking treatment for their condition. (REF# 11826)
This study seeks adults who are candidates for implantation of, or already implanted with, a BIOTRONIK Lumax HF-T or DR-T device. (REF# 19400)
This study seeks adult participants who have been diagnosed with an abnormal heart rhythm called atrial fibrillation (AF). (REF# 18744)